Navigation Links
BioInnovation Institute in Akron Launched

Public-private partnership commits more than $80 million to create a

leading center for medical excellence; collaboration will focus on

biomaterials and medical devices

AKRON, Ohio, Oct. 16 /PRNewswire/ -- Fueled by a grant from the John S. and James L. Knight Foundation, five leading medical and educational institutions today announced the creation of the BioInnovation Institute in Akron -- a unique collaboration that will expand upon the region's rich legacy in industrial and materials science to pioneer the next generation of life- enhancing and life-saving innovation for the 21st Century.

Founders of the BioInnovation Institute include Akron Children's Hospital, Akron General Health System, Northeastern Ohio Universities Colleges of Medicine and Pharmacy (NEOUCOM), Summa Health System, and The University of Akron.

"The BioInnovation Institute in Akron is uniquely positioned to meld the region's traditional strengths in research, education, and world-class health to create transformational new technologies with a direct impact on the people we collectively serve," said William H. Considine, chairman of the BioInnovation Institute and president and chief executive officer of Akron Children's Hospital. "Our vision of making Akron a leader in the biomaterials field is absolutely attainable, given Akron's intellectual, educational, research, and commercial strengths."
Mr. Considine said the BioInnovation Institute's goals include:

* Creating a nationally distinctive center of excellence at the

intersection of biomaterials and medicine

* Translating leading edge research into life-saving medical devices

* Improving the health of the community

* Rapidly growing annual biomaterials-related research funding across the


* Increasing investment by national firms into regional biomedical start-

ups and companies

* Increasing employment opportunities for those educated locally and

drawing talent from around the globe

* Adding thousands of new jobs in the region by 2018

John S. and James L. Knight Foundation Leads Funding Effort

Funding to create the BioInnovation Institute in Akron began with a $20 million grant from the John S. and James L. Knight Foundation, the lead funder and founding partner of the Institute. The foundation served as a catalyst, bringing the operating partners together and supporting the development of the Institute from concept to reality.

In unveiling the grant for the Institute, Dr. W. Gerald Austen, chairman of Knight Foundation, said the partnership for the BioInnovation Institute in Akron represents "something bigger and more powerful than the sum of its parts -- something transformational."

"It is our hope that the Institute will make Akron a world-class center for bioinnovation," Dr. Austen said.

Knight Foundation has committed more than $117 million in grants to Akron since its founding in 1950, with a recent focus on local economic development to "help create transformational change." Akron is the hometown of Knight Foundation's founders, John S. and James L. Knight.

In addition to the grant from the Knight Foundation, each of the founding organizations are contributing $4 million in matching funds. The State of Ohio has also contributed $8.675 million in previously announced Third Frontier state-development grants.

"We expect these initial contributions will be the genesis of a larger effort," said Eric D. Fingerhut, chancellor, Ohio Board of Regents. "The state, the Knight Foundation, and the founding members of the BioInnovation Institute have joined together to make the vision of transformative healthcare a reality in Akron, a vital step in driving innovation for the region and Ohio."

FirstEnergy Corp. became the first community supporter of the BioInnovation Institute with a pledge of up to $10 million over the next 10 years, expressing long-term support and confidence in the Institute's transformative impact on the local and regional economy. The funds have been designated to support capital expenditures for energy-efficiency technologies at Institute facilities.

"FirstEnergy is proud to invest in the long-term sustainability of the BioInnovation Institute in Akron," said Anthony J. Alexander, president and chief executive officer of FirstEnergy. "Through the collective strength of the founding organizations, we believe the Institute can help make a transformative change in our region, leading to a future in which the Akron area is viewed as a vital center for cutting-edge research, education and healthcare."

Institute to Combine Physical and Virtual Centers of Excellence

The BioInnovation Institute in Akron will employ a number of physical and virtual entities as its partners collaborate in the coming months and years. These entities will be located in Akron and will likely include:

* The Orthopedic Research Institute of Northeastern Ohio

* The Center for Biomaterials and Medicine -- a research facility to be

located on the campus of The University of Akron

* A Center for Health Care Training, which will also include educational

and office facilities for NEOUCOM

* A Medical Device Concept Laboratory

* A Center for Clinical Trials

Local, Global Experts to Lead BioInnovation Institute

Individually, each of the founding institutions is a leader in its respective areas of expertise. Together, they represent:

* Leading U.S. biopolymer program

* Highly-regarded academic and clinical orthopedic programs with

nationally ranked residencies

* Millions of dollars invested annually in academic programs, clinical

research, and commercialization efforts

* Industry-leading researchers, physicians, and medical residents

Mr. Considine said a nationwide search has begun for an executive director who, with a board of directors that will include the founding partners and other national and global biomaterials and medical experts, will lead the BioInnovation Institute. Aram Nerpouni, vice president of the regional biomedical business accelerator BioEnterprise, will serve as interim director during the search. BioEnterprise facilitated the development of the BioInnovation Institute in Akron and will support its efforts.

Faculty members will include researchers, physicians, and educators from the partner organizations.

"With the launch of the BioInnovation Institute in Akron today, we mark the beginning of the next chapter in the history of Akron and the next major milestone in the development of the biomaterials industry worldwide," concluded Akron Mayor Don Plusquellic. "This collaboration will empower our region's academic, medical, research, and industrial organizations to take their rightful place as leaders in biomaterial and medical innovation."

About the BioInnovation Institute in Akron:

The BioInnovation Institute in Akron is transforming Akron into a model for biomedical discovery and enterprise. Through the collaboration of complementary research, education, and health institutions, the goal of this initiative is to expand Akron's rich legacy in materials science to pioneer the next generation of life-enhancing and life-saving innovation for the 21st Century. For more information, visit

About the John S. and James L. Knight Foundation:

The John S. and James L. Knight Foundation promotes journalism excellence worldwide and invests in the vitality of communities in the United States where the Knight brothers once owned newspapers. Knight Foundation invests in ideas and projects that can lead to transformational change.

SOURCE BioInnovation Institute in Akron
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. University of Maryland, Baltimore BioPark Signs Gliknik Inc. as First Tenant in Its BioInnovation Center in Building Two
2. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
3. Southern Research Institute Licenses Anti-Cancer Drug Compound to Virium Pharmaceuticals
4. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
5. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
6. Solazyme Selected for National Institute of Standards and Technology Award
7. HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
8. Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million
9. National Institutes of Health Awards $25.5M Contract to SRA
10. The USC Stevens Institute for Innovation Opens Shop on US Health Sciences Campus
11. Infectious Disease Research Institute Receives Grant for Acquisition of Core Research Equipment from M.J. Murdock Charitable Trust
Post Your Comments:
(Date:3/24/2017)... March 24, 2017 On Thursday, ... session at 5,817.69, down 0.07%; the Dow Jones Industrial ... the S&P 500 closed at 2,345.96, marginally dropping 0.11%. ... closed in green, 4 sectors finished in red, and ... has initiated reports coverage on the following Biotechnology ...
(Date:3/24/2017)... 24, 2017 Agenus Inc. (NASDAQ: AGEN), an ... and cancer vaccines, today announced participation at the following ... William Blair and Maidstone Life Sciences conference "Cancer Immunotherapy ... New York, NY . Agenus will ... at 9:40 am: Robert B. Stein , M.D., ...
(Date:3/23/2017)... ... ... Lajollacooks4u is proud to announce it has become the premiere team-building cooking event company in ... the world, such as Illumina, HP and Qualcomm, and is ranked #1 in its category ... due to its new team building format, a way for teams to not only interact ...
(Date:3/23/2017)... 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) (NW ... therapies for solid tumor cancers, today announced that ... it announced last Friday, March 17, 2017. ... investors securities totaling 28,843,692 shares, comprised of 18,843,692 ... shares of Class C Warrants pre-funded at the ...
Breaking Biology Technology:
(Date:3/2/2017)... , March 2, 2017 Australian stem cell ... (ASX: CYP), has signed an agreement with the Monash ... Monash Biomedicine Discovery Institute and Department of Pharmacology at ... a further preclinical study to support the use of ... asthma.  Asthma is a chronic, long ...
(Date:2/27/2017)...   Strategic Cyber Ventures , the industry,s first ... $3.5 million investment in  Polarity , the first commercial ... DC based and is led by cybersecurity veterans ... Ron Gula , also a longtime cybersecurity veteran and ... series A round of funding. This new funding will ...
(Date:2/21/2017)... -- Der weltweite Biobanking-Sektor wird bis zum ... mit mehr als 50 Vertretern aus verschiedenen Branchen wurde aber ... diese Prognose zu realisieren. ... Zu den Schwierigkeiten für ... für die Biobank, die Implementierung Zeit sparender Technologien, ein ...
Breaking Biology News(10 mins):